Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis

Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis

Abstract Background Diabetic Foot Infection (DFI) guidelines recommend empiric methicillin-resistant Staphylococcus aureus (MRSA)-targeted therapy in settings where there is high prevalence of MRSA infections or in cases of severe infection; however, they do not provide recommendations for de-escala...

Full description

Bibliographic Details
Main Authors: Gaielle Harb, Teri Hopkins, Linda Yang, Kathleen Morneau, Jose Cadena-Zuluaga, Elizabeth Walter, Christopher Frei
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Infectious Diseases
Subjects:
Methicillin-resistant Staphylococcus aureus
Polymerase chain reaction
Diabetic foot
Antibacterial agents
Drug utilization
Online Access:https://doi.org/10.1186/s12879-023-08248-2

Internet

https://doi.org/10.1186/s12879-023-08248-2

Similar Items